Stevanato Group (STVN)
(Delayed Data from NYSE)
$20.20 USD
+0.09 (0.45%)
Updated Sep 11, 2024 04:00 PM ET
After-Market: $20.20 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value F Growth B Momentum D VGM
Price, Consensus and EPS Surprise
STVN 20.20 +0.09(0.45%)
Will STVN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for STVN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for STVN
SDZNY vs. STVN: Which Stock Is the Better Value Option?
Implied Volatility Surging for Stevanato Group (STVN) Stock Options
STVN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Stevanato Group (STVN) Q2 Earnings Match Estimates
Jazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth
Analysts Estimate Stevanato Group (STVN) to Report a Decline in Earnings: What to Look Out for
Other News for STVN
Stevanato Group SpA (STVN) Shares Down 3.65% on Sep 9
Morgan Stanley Keeps Their Hold Rating on Stevanato Group (STVN)
Stevanato Group to Present at Upcoming Investor Conferences
Stevanato Group SPA's Meteoric Rise: Unpacking the 17% Surge in Just 3 Months
Conestoga Capital Advisors Q2 2024 Commentary